CN101342286B - Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny - Google Patents

Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny Download PDF

Info

Publication number
CN101342286B
CN101342286B CN2008101464826A CN200810146482A CN101342286B CN 101342286 B CN101342286 B CN 101342286B CN 2008101464826 A CN2008101464826 A CN 2008101464826A CN 200810146482 A CN200810146482 A CN 200810146482A CN 101342286 B CN101342286 B CN 101342286B
Authority
CN
China
Prior art keywords
hyperosteogeny
portions
intervertebral disc
lumbar intervertebral
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101464826A
Other languages
Chinese (zh)
Other versions
CN101342286A (en
Inventor
李育民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101464826A priority Critical patent/CN101342286B/en
Publication of CN101342286A publication Critical patent/CN101342286A/en
Application granted granted Critical
Publication of CN101342286B publication Critical patent/CN101342286B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Chinese medicinal composition which is used for treating the proplapse of lumbar intervertebral disc and Hyperosteogeny. The composition is prepared from raw materials according to the following weight portions: 5 portions of saffron, 20 portions of dragon blood, 10 portions of soil insects, 5 portions of frankincense, 5 portions of myrrh and 0.5 portion of borneol. The composition has the functions of activating blood circulation, dissipating blood stasis, promoting qi, eliminating pains, dispelling wind, eliminating dampness, dredging collaterals and stopping pains, and has excellent effects on treatment of the proplapse of lumbar intervertebral disc and the Hyperosteogeny.

Description

A kind of Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny
Technical field
The present invention relates to field of medicaments, specifically, the present invention relates to a kind of Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny.
Background technology
Prolapse of lumbar intervertebral disc is a kind of commonly encountered diseases, frequently-occurring disease, and the trend that increases is year by year arranged.Its morbidity is to be broken by the fibrous ring of lumbar intervertebral disc, and vertebral pulp is outstanding, compressing dural sac, nerve root and cause.Prolapse of lumbar intervertebral disc have two kinds, a kind of is sudden prolapse of lumbar intervertebral disc, another kind is the potentiality prolapse of lumbar intervertebral disc.Paroxysmal is to bear the pressure of over loading by wound or waist and cause intervertebral disk hernia or extrude.The potentiality prolapse of lumbar intervertebral disc is hypertrophy, the intervertebral disk retrogression pathological changes because of vertebral body; The unstability or the subluxation of the intervertebral disc inflammatory reaction twisting of joints; Lumbar vertebra lateral bending and cause multilevel twisting of joints unstability; And latency such as the fragile degeneration of the fibrous ring that causes of Inheritance property causes, no matter is sudden prolapse of lumbar intervertebral disc or potentiality prolapse of lumbar intervertebral disc, all brings harm and painful to the patient.
The arthromyodynia category of the primary disease ownership traditional Chinese medical science.Chinese medicine thinks, the wind-cold damp pathogen invasion and attack, and acute and chronic trauma causes meridians impatency, QI-blood circulation smooth and cause a disease, so forefathers have " numbness person closes also ", the saying of " bitterly then obstructed, general rule is not bitterly ".The primary disease primary symptom is a lumbago and skelalgia, and it causes the machine-processed more complicated of lumbago and skelalgia, but mainly is mechanical pressure and two aspects of chemical stimulation.Mechanical pressure occurs formerly, after chemical stimulation occurs in.Aseptic inflammations such as the compressing of outthrust stimulates can cause nerve root hyperemia, ooze out, edema, degeneration, adhesion are secreted algogenic substances such as Kallidin I then.
A large amount of cases prove that prolapse of lumbar intervertebral disc is easy to make a definite diagnosis through means such as X-ray, CT, magnetic resonance.To the treatment of prolapse of lumbar intervertebral disc, at present doctor trained in Western medicine with traction, computer reset, methods treatments such as canalis sacralis therapy, operation, the traditional Chinese medical science is treated with methods such as acupuncture, cupping, massage, extract orals.Though said method can alleviate mechanical pressure effectively, it can not eliminate chemical stimulation effectively, remove the swelling and the congestion pain in partial wind-cold damp pathogen and affected part, and the course of treatment is longer.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny.
In order to realize the object of the invention; The present invention provides a kind of Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny, and it is the medicament of being processed according to weight portion by following bulk drugs: 0.5 part of 5 parts of Stigma Crocis, 20 parts of Sanguis Draxonis, 10 parts of eupolyphage sece steleophagas, 5 parts of Olibanums, 5 parts of Myrrhas and Borneolum Syntheticum.Wherein Stigma Croci has the effect of blood circulation promoting and blood stasis dispelling, collateral dredging; Sanguis Draxonis has clots absorbing, analgesic effect; Eupolyphage sece steleophaga has the effect of removing blood stasis, reunion of fractured tendons and bones; Olibanum has the effect of blood-activating and qi-promoting, reducing swelling and alleviating pain; Myrrha has the effect of blood-activating and qi-promoting, reducing swelling and alleviating pain; Borneolum Syntheticum has the effect of the analepsia of having one's ideas straightened out, clearing away heat to alleviate pain.
Said pharmacy optimization is a plaster.
Chinese medicine composition of the present invention has blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, and expelling wind and removing dampness, the effect of removing obstruction in the collateral to relieve pain has good effect to treatment prolapse of lumbar intervertebral disc and hyperosteogeny.
The specific embodiment
Following examples are used to explain the present invention, but are not used for limiting scope of the present invention.
Embodiment 1
Get Stigma Croci 5 grams, Sanguis Draxonis 20 grams, eupolyphage sece steleophaga 10 grams, Olibanum 5 grams, Myrrha 5 grams and Borneolum Syntheticum 0.5 gram, pulverize, cross 80 mesh sieves and make powder.Semen Ricini 50 restrained into add above-mentioned powder behind the pasty state, smash into paste, be divided into 10 and paste.
Experimental example
1, clinical data
1.1, physical data
Among the 80 routine patients, male 56 examples, women 24 examples: 25 years old~75 years old age; The course of disease did not wait in 1 month-10 years; 28 examples of companion's lumbar vertebra hyperosteogeny, 10 examples of companion's spinal canal stenosis.
1.2, diagnostic criteria
With reference to formulating about the diagnostic criteria of prolapse of lumbar intervertebral disc in " traditional Chinese medical science disease diagnosis criterion of therapeutical effect "; All case all has typical long-term chronic back pain history, and the companion begins to lower limb radiating pain or numbness, scoliosis from buttocks; The waist physiologic radian disappears, and straight-leg raising test is positive.All case is all done the lumbar vertebra CT examination, shows: prolapse of lumbar intervertebral disc.
2, Therapeutic Method
2.1, medicine
Prepare plaster according to embodiment 1 described method.
2.2, method for using
Plaster is spread on painful area, changed once 20 days courses of treatment, totally 2 courses of treatment in 2 days.Forbid taking maror during the drug of topical application, forbid drinking.
3, criterion of therapeutical effect
With reference to formulating about the criterion of therapeutical effect of prolapse of lumbar intervertebral disc in " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ".
Clinical recovery: the complete obiteration of lumbago and skelalgia symptom, upright walking freely, have a medical check-up: straight-leg raising test 70 degree, can recover former work; Take a turn for the better: the lumbago and skelalgia sx, the waist movable function improves; Heal in the end: symptom and sign does not have improvement, straight-leg raising test 30 degree.
4, therapeutic outcome
72 examples of fully recovering, 8 examples that take a turn for the better, the end is 0 example more.

Claims (2)

1. Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny is characterized in that it is the medicament of being processed according to weight portion by following bulk drugs: 0.5 part of 5 parts of Stigma Crocis, 20 parts of Sanguis Draxonis, 10 parts of eupolyphage sece steleophagas, 5 parts of Olibanums, 5 parts of Myrrhas and Borneolum Syntheticum.
2. Chinese medicine composition according to claim 1 is characterized in that said medicament is a plaster.
CN2008101464826A 2008-09-01 2008-09-01 Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny Expired - Fee Related CN101342286B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101464826A CN101342286B (en) 2008-09-01 2008-09-01 Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101464826A CN101342286B (en) 2008-09-01 2008-09-01 Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny

Publications (2)

Publication Number Publication Date
CN101342286A CN101342286A (en) 2009-01-14
CN101342286B true CN101342286B (en) 2012-07-04

Family

ID=40244477

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101464826A Expired - Fee Related CN101342286B (en) 2008-09-01 2008-09-01 Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny

Country Status (1)

Country Link
CN (1) CN101342286B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104147289A (en) * 2014-08-13 2014-11-19 刘天才 Plaster for treatment of cervical and lumbar rheumatism hyperplasia
CN106511685A (en) * 2016-10-25 2017-03-22 王德福 Muscle and bone hyperplasia treatment patch
CN107095945A (en) * 2017-04-01 2017-08-29 薛艳修 It is a kind of to be used to treat ointment containing red precipitate of osteopathy and preparation method thereof
CN109908246A (en) * 2019-03-19 2019-06-21 亳州学院 The external application Chinese medicine formula for treating lumbar pain orthopaedic disease
CN110038077A (en) * 2019-05-31 2019-07-23 王亮 A kind of plaster for treating osteoproliferation, spur

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129858A (en) * 2007-08-27 2008-02-27 朱芳 Plaster for treating cervical vertebra/lumbar disease
CN101129681A (en) * 2007-08-27 2008-02-27 朱芳 Plaster for treating arthritis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129858A (en) * 2007-08-27 2008-02-27 朱芳 Plaster for treating cervical vertebra/lumbar disease
CN101129681A (en) * 2007-08-27 2008-02-27 朱芳 Plaster for treating arthritis

Also Published As

Publication number Publication date
CN101342286A (en) 2009-01-14

Similar Documents

Publication Publication Date Title
CN1706441A (en) Arthralgia treating plaster
CN101342286B (en) Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny
CN1895549A (en) Soothe tendons and activating-blood anodyne plaster
CN102908442B (en) Composition for treating traumatic injuries and medicinal liquor thereof
CN1876084A (en) Ointment for orthopedics
CN100998823A (en) Plaster for treating osteosis, protrasion of lumbar intervertebral disc
CN102342983B (en) Chinese medicinal composition for treating pain in the legs and numbness of the extremities and preparation method of preparation thereof
CN103463261B (en) Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation
CN1255169C (en) Medicine for relaxing muscles and tendons and activiating colleterals and pain dispelling
CN1135909A (en) Medicine for hyperosteogeny and wind-cold syndrome
CN102526482A (en) Traditional Chinese medicine preparation for treating lumbar disc herniation
CN104587226A (en) Traditional Chinese medicine for treating ankylosing myelitis and lumbar disc herniation and use method thereof
CN104800463A (en) Plaster for orthopaedics
CN101244135A (en) Medicine label for treating rheumatism, hyperosteogeny
CN101214346B (en) Chinese medicine emplastrum for treating pain of vertebrae cervicables lumbar intervertebral disc
CN104223873B (en) A kind of Traditional Chinese medicine health care pillow and preparation method thereof
CN103656078A (en) Traditional Chinese medicine for treating bone diseases
CN102319316B (en) Rapid bone hyperplasia healing agent
CN103211867A (en) External traditional Chinese medicine composition used for treating sprain
CN102614350A (en) Chinese medicine for treating cervical spondylosis
CN100509052C (en) Traditional Chinese medicine for treating bone medullitis
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN106620104A (en) External plaster for treating removing dampness and relieving pain and preparation method thereof
CN1864722A (en) A pharmaceutical composition for treating muscles and bones pain and lumbar intervertebral disc protrusion
CN106729400A (en) A kind of exterior-applied medical wine for the treatment of of arthritis

Legal Events

Date Code Title Description
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Li Yumin

Document name: Notification of Passing Preliminary Examination of the Application for Invention

C06 Publication
PB01 Publication
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Li Yumin

Document name: Notification of Publication of the Application for Invention

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120704

Termination date: 20190901

CF01 Termination of patent right due to non-payment of annual fee